Skip to main content

A perception into binary and ternary copper (II) complexes: synthesis, characterization, DFT modeling, antimicrobial activity, protein binding screen, and amino acid interaction


Ensuring healthy lives and promoting well-being for all at all ages is the third goal of the sustainable development plan, so it was necessary to identify the most important problems that threaten health in our world. The World Health Organization declared that antibiotic resistance is one of the uppermost global public health threats facing humanity and searching for new antibiotics is slow. This problem can be approached by improving available drugs to combat various bacterial threats. To circumvent bacterial resistance, three copper(II) complexes based on the pefloxacin drug were prepared and characterized using analytical, spectroscopic, and thermal techniques. The resulting data suggested the formation of one octahedral binary and two distorted square pyramidal ternary complexes. Fluorescence spectra results revealed the formation of a turn-on fluorophore for amino acid detection. Computational calculations investigated quantum and reactivity parameters. Molecular electrostatic potential profiles and noncovalent bond interaction-reduced density gradient analysis indicated the active sites on the complex surface. The complexes were subjected to six microbial species, where the octahedral binary complex provoked its antimicrobial potency in comparison with ternary complexes. The enhanced antimicrobial activity against gram-negative bacterium E-coli compared to gentamicin was exhibited by the three complexes. Docking simulation was performed based on the crystal structure of E. coli and S. pneumoniae receptors using 5I2D and 6O15 codes. The binary complex exhibited a potent fitness score with 5I2D (TBE = − 107 kcal/mol) while ternary complexes displayed the highest docked score of fitness with 6O15.

Peer Review reports


The wide use of antibiotics demonstrated the key issue in the rise of multidrug resistance in pathogens, which is why the clinical efficiency of the existing drugs became defenseless [1], causing a variety of illnesses that can end in death. Consequently, this permit scientists to develop novel drugs or modify the existing commercial drugs to enhance their efficiency to combat numerous diseases, which may cause serious problems to humankind [2].

Fluoroquinolones comprise a class of antibiotics that can effectively inhibit the replication of bacterial DNA gyrases [3, 4]. Fluoroquinolones form a ternary complex with the DNA and bacterial enzymes, cleave the bacterial DNA, and encumber bacterial replication [3,4,5] which in turn treat severe infections [6].

To avoid the problem of misuse of these antibiotics, the complexation of fluoroquinolones with transition and non-transition metal ions was used as an alternative to conventional drugs [7,8,9,10,11]. However, the combinations of metal with pharmaceuticals expand the activity of the drug, reduce their toxicity, improve the ability to act as regulators of gene expression and serve as microbiological tools [12,13,14,15]. Fluoroquinolones coordinate with metal ions as bidentate ligands via the groups which are responsible for their antimicrobial activity, one carboxylate and pyridone oxygens [7,8,9,10,11], producing a stable chelated complex [10, 11].

Copper fluoroquinolone complexes proved to be the most stable complexes, copper complexes also presented bactericidal and fungicidal action [16, 17] and displayed high activity against a variety of diseases, and tumors. Besides, fluoroquinolone copper(II) complexes bind strongly to calf-thymus DNA (CT DNA) and human or bovine serum albumin protein with high binding constant values [18].

More active mixed-ligand copper complexes which are prepared from primaryligands as fluoroquinolones and a secondary ligand as heterocyclic ligand containing nitrogen donor, for example, 2,2’-bipyridine and 1,10-phenanthroline, bathophenanthroline, imidazole, and glycine amino acid [19,20,21,22,23,24,25,26]. On this basis, Pefloxacin (HPf), [1-ethyl-6-fluoro-7-(4-methylpiperazin- 1-yl)-4-oxo-quinoline-3- carboxylic acid] (Scheme 1), belongs to the family of antibacterial agents that hinders bacterial DNA replication [27].

Scheme 1
scheme 1

Synthesis of copper(II) based pefloxacin complexes

Despite pefloxacin had [27], high bioavailability, and a long half-life various bacteria have developed resistance against it and various strategies to enhance its potency were adopted.

Pefloxacin metal complexes displayed higher antimicrobial inhibitory activity than free pefloxacin [27]and revealed a higher intrinsic binding constant to CT-DNA [28, 29].

Mixed ligands metal complexes of pefloxacin-imidazole and pefloxacin and ascorbic acidwere synthesized, characterized, tested against various microorganisms, [27]. To the best of our knowledge, the number of metal pefloxacin complexes reported in various studies is quite limited, specifically, copper pefloxacin mixed ligands using the nitrogen donor heterocyclic ligands 1,10-phenanthroline (phen) and 2,2′-bipyridine (bipy) as secondary ligands, these ligands proved to be more active against microorganisms and showed promising insights against resistant bacterial strains [19,20,21,22,23,24,25,26]. As part of our research area is developing powerful metal-based compounds against antibiotic resistance [17,18,19], herein we report the synthesis of pefloxacin copper complexes in the absence and presence of 1,10-phenanthroline (phen) and 2,2′-bipyridine (bipy), to study the mode of coordination and the biological activities of the obtained complexes.

The resultant copper(II) complexes were fully characterized using analytical, molar conductance, spectroscopic and thermal techniques.

The fluorescence spectra of pefloxacin were studied both in the presence and absence of copper ions, and the effect of various amino acids on the fluorescence properties of the copper-pefloxacin complex was explored.

In addition, density functional theory (DFT) calculations were performed to estimate some important parameters related to their activity and stability. The type of interaction between the ligand and receptor in molecular docking was examined by natural bond orbital (NBO) analysis. The electrophilic and nucleophilic molecular centers were predicted by molecular electrostatic surface potential (MEP) analysis.The antimicrobial activity was evaluated against bacterial strains, B. subtilis, S. pneumoniae, E. coli, P. aeruginosa, and C. albicans and A. fumigatus as fungal strains. Drug design and bioinformatics tools were demonstrated to illustrate different interaction types present between the docked compound and protein. E. coli and S. pneumoniae target using 5I2D and 6O15 codes were taken as receptors for the bio-ligand and its copper complexes.


Materials and methods

Pefloxacin mesylate dihydrate (HPf), 1,10-phenanthroline (phen), and 2,2′-bipyridine (bipy) were purchased from Sigma–Aldrich Chemical Co. Alanine, proline, aspartic acid, copper nitrate trihydrate, potassium hydroxide, potassium dihydrogen orthophosphate, and sodium hydroxide were used as received from Merck Chemical Company. Nitric acid (68%), Hydrochloric acid, dimethyl sulfoxide (DMSO, Aldrich), acetone, diethyl ether, and ethanol (BDH-PROLABO), were of analytical grade.

Physical measurements

Carbon, hydrogen, and nitrogen analysis were recorded using an elemental analyzer Perkin-Elmer 240B. Complexometric titration was carried out to determine the copper content [30]. An electrothermal melting point apparatus detected the melting points. HI 8033 HANNA conductivity meter was used to measure the molar conductivity of a 1.00×10−3 M DMSO solution at 25.0 ±1.0 °C. A 500 UV–Vis spectrophotometer recorded the ultraviolet–visible spectra for 1.00×10-5–5.00×10−3M DMSO solutions at room temperature. A Perkin-Elmer model IS 55 fluorescence spectrometer measured the fluorescence spectra at 25.0 ±1.0 °C with freshly prepared solutions. The pH measurements were performed using a Digital Orion pH/ISE meter. FT-IR spectra were studied in the range of 4000-500 cm-1 at 25 °C from KBr pellets of 3 mm thickness, using a Perkin-Elmer FT-IR 1650 Spectrophotometer. The mass spectra were performed by the electron ionization technique at 70 eV using a Thermo Scientific Singing Instrument in Cairo University. Electron paramagnetic resonance (EPR) spectra were studied by an EPR spectrometer (Bruker, EMX) at 25.0 ±1.0 °C, X-band frequency 9.8 GHz, with modulation frequency 100 kHz, standard cylindrical resonator (ER 4119HS) and external standard DPPH. Thermal analyses were carried out on LINSEIS STA PT1000 thermogravimetric analyzer in the temperature range of 25 °C–1000 °C with a maximum weight sample of 10 mg placed in a platinum crucible under a nitrogen atmosphere with a 30 mL/min flow rate and a heating rate of 10 °C/min.

Synthesis of copper complexes

Synthesis of [Cu(Pf)2(H2O)2]0.3H2O

A solution of copper nitrate trihydrate (40 mg; 0.166 mmol) in ethanol (10 mL) was added to a mixture of HPf (151.8 mg; 0.33 mmol) and KOH (19.0 mg; 0.33 mmol) in ethanol (15 mL). The resulting mixture was stirred for approximately 24 h at 25 °C (Scheme 1). A blue precipitate was obtained, filtered off, washed with distilled water followed by ethanol and diethyl ether, and dried under vacuum at 60 °C for 24 h.

Yield 63%; m.p. 250 °C; Color Blue. Anal. Calc. for C34H48F2N6 O11Cu, (%): C, 50.08; H, 5.91; N, 10.26; Cu, 7.77. Found (%): C, 49.91; H, 5.74; N, 10.23; Cu, 7.37. Λm (Ω-1mol-1cm2) = 4; FTIR (ν, cm-1): (O-H/H2O) 3414, ν(C=O) pyridone 1627, ν(COO-)asym1585, ν(COO-)sym1382, (M-O) 496. UV–Vis (λmax, nm): 282, 344, 723,967. ESR: g= 2.31, g= 2.07; ˂g˃= 2.15; G=4.5; A||=170; ƒ=136; α2=0.85.

Synthesis of [Cu(HPf)(bipy)(NO3)]NO3.2H2O

A solution of copper nitrate trihydrate (80 mg; 0.33 mmol) in ethanol (10 ml) was added to a mixture of bipy (52 mg; 0.33 mmol) and pefloxacin (151.8 mg; 0.33 mmol) in ethanol (20 ml). The formed mixture was stirred for approximately 24 h at 25 °C (Scheme 1). A greenish-blue precipitate was obtained, separated out, washed with distilled water, ethanol then diethyl ether, and finally dried under vacuum.

Yield 78%; m.p. 278 °C; Color Greenish blue solid. Anal. Calc. for C27H32FN7 O11Cu (%): C, 45.48; H, 4.52; N, 13. 75; Cu, 8.91. Found (%): C, 45.50; H, 4.50; N, 13.70; Cu, 8.64. Λm (Ω-1mol-1cm2) = 20; FTIR (ν, cm−1): (O-H/H2O) 3434, ν(C=O) pyridone 1635, ν(COO-)asym 1589, ν(COO-)sym 1386, (M-O) 517. UV–Vis (λmax, nm): 283, 310,347,419, 649. ESR: g=2.27, g=2.06; ˂g˃= 2.13; G=4.5.

Synthesis of [Cu(HPf)(phen)(NO3)]NO3.2H2O

A solution of copper nitrate trihydrate (80 mg; 0.33 mmol) in ethanol (10 ml) was added to a mixture of phen (66 mg; 0.33 mmol) and pefloxacin (151.8 mg; 0.33 mmol) in ethanol (20 ml). The obtained mixture was stirred for approximately 24 h at 25 °C (Scheme 1). A dark blue precipitate was obtained, separated off, washed with distilled water several times followed by hot ethanol and diethyl ether, and finally dried under vacuum for 24 h.

Yield 80%; m.p. 260 °C; Color Dark blue solid. Anal. Calc. for C29H32FN7 O11Cu (%): C, 47.25; H, 4.38; N, 13.30; Cu, 8.62. Found (%): C, 47.20; H, 4.37; N, 13.29; Cu, 8.41. Λm (Ω-1mol-1 cm2) = 30; FT‐IR (ν, cm-1): (O-H/H2O) 3448, ν(C=O) pyridone 1626, ν(COO-)asym 1584, ν(COO-)sym 1384, (M-O) 520. UV–Vis (λmax, nm): 276, 342,418, 654. ESR: g1=1.97, g2=2.14, g3=2.57; ˂g˃= 2.23; Rr =0.40.

Fluorescence studies

Pefloxacin, a stock solution of 2.00x10-7 M, was synthesized by dissolving an accurate mass of pefloxacin in double-distilled water and recording its fluorescence intensity. Different concentrations of Cu(NO3)2.3H2O solutions (5.00x10-3 –1.00x10-7 M) were added to the solution, and their fluorescence intensity was measured.

Amino acid detection

Different concentrations of three amino acids, namely, aspartic acid, proline, and alanine (1.3x10-1 –1.00x10-3 M), were added gradually to the prepared copper complex solution. In this investigation, 3 mL of 0.01M phosphate buffer (pH 7) was added to the mixture.

The buffer solutions were synthesized by mixing the proper volumes of 0.1MNaOH and 0.01M KH2PO4 for pH 5–10. Immediately after sample preparation the spectra were recorded by scanning the wavelength range from 350 to 600 nm at an optimum excitation wavelength of 330 nm.

Computational methodology

The Gaussian 09 program [31] is a powerful software for the structural and electronic analysis of a large number of molecules. The molecular properties were studied using the B3LYP method [32, 33] with mixed basis set LanL2DZ for the metal and 6-311G(d,p) for C,H,O,N and F of the ligand [34, 35]. Full optimization was applied to pefloxacin and its binary and ternary copper(II) complexes to produce important geometrical parameters that indicate the actual structure of the synthesized complexes. A computational study was performed on gas state, quantum, and reactivity parameters, including frontier molecular orbitals (FMO) energies, electronegativity, ionization potential, electron affinity, global descriptors (chemical softness and hardness), and dipole moment. The Chemcraft [36] and Gauss view [37] programs envisage the calculated optimized structures and produce some calculations based on the FMOs. Natural bond orbital (NBO) analysis and molecular electrostatic potential (MEP) were studied for the optimized structures at the DFT/B3LYP level [32, 33]. To demonstrate the kind of interactions between the atoms of compounds, noncovalent interaction analysis was performed on the optimized compounds.

Antimicrobial activity studies

A modified Kirby-Bauer disc diffusion technique [38,39,40,41] was carried out to evaluate the antimicrobial activity of pefloxacin and its Cu(II) complexes against bacterial strains (B. subtilis, S. pneumoniae, E. coli, and P. aeruginosa) and against fungal strains (C. albicans and A. fumigatus). A stock solution of 5 mg/mL prepared by dissolving pefloxacin and the copper complexes in dimethyl sulfoxide. Twofold dilution of the stock solution was carried out to obtain solutions of several concentrations. The antibacterial and antifungal activities of the investigated compounds were determined by the filter paper disc method [42], and the diameters of the inhibition zones (mm) were measured to evaluate the activities. Media with DMSO was used as a control. Standard discs of gentamicin and ampicillin (antibacterial agents; 10 μg/disc) and amphotericin B (antifungal agent; 10 μg/disc) served as positive controls for antimicrobial activity, while negative control was employed as a filter disc soaked with 10 µl of dimethyl sulfoxide.

Molecular docking simulation

Docking simulation was performed based on the crystal structure of E. coli and S. pneumonia receptors using 5I2D [43] and 6O15 [44] codes downloaded from the Protein Data Bank (PDB) (

The software iGemdock 2.1 [45] was used for the current calculations, and Chimera 1.13.1progrsm [46] was used for the visualization of ligand-target interactions. The docking performance has a default setting based on X-ray diffraction with 2.30 Å resolution and 0.193 R-factor. Docking accuracy settings (with GA parameters) were attuned as a standard docking with a size of population 200, generations 70 and number of solutions 2. The receptor preparation was performed by eliminating any ions, small ligands and water molecules and adding polar hydrogens.

Results and discussion

The prepared copper(II) complexes (Scheme 1) are stable at room temperature, freely soluble in dimethyl sulfoxide but insoluble in most organic solvents and water. The detected lower molar conductivity value for [Cu(Pf)2(H2O)2].3H2O (3-4 S.cm2.mol-1) suggested a nonelectrolytic nature of the complex. The molar conductivity value of 20-50 S.cm2.mol-1 for [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O indicated that both complexes are 1:1 electrolytes [47].

Diverse crystallization methods were carried out to gain a crystal appropriate for structure determination using X-ray crystallography. Nevertheless, the complexes were collected as microcrystalline products.

FT-IR spectroscopy

The FT-IR spectra of the free ligand and its complexes showed a broad split band in the region 3450-3414 cm-1 corresponding to ν(O-H/H2O). The strong bands at 1718 and 1630 cm−1 in the spectrum of pefloxacin assigned to carboxylic and pyridone ν(C=O) moieties, respectively [27, 48]. However, in the spectra of complexes, the pyridone ν(C=O) was shifted, appearing in the range 1626-1635 cm-1, while carboxylic ν(C=O) disappeared, and asymmetrical and symmetrical vibrations bands for of ν(C=O) were displayed at 1568-1589 cm-1 and 1350-1386 cm-1.

The Δν values were 200-218, indicating monodentate binding to copper(II) ions. The ternary complexes [Cu(HPf)(bipy)(NO3)]NO3.2H2Oand [Cu(HPf)(phen)(NO3)]NO3.2H2O showed bands at 2712 and 2714 cm-1 respectively, corresponding to ν(H-N+) of the biperazine ring, indicating the neutral zwitterionic form of pefloxacin. Two new bands were shown at 1485,1386 and 1481,1384 cm-1 for [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O due to binding of the nitrato group to the copper atom. The ΔνNO3 for these complexes are 99 and 97 cm-1, respectively, representing a monodentate coordination mode of the nitrate group to the copper(II) ion, whereas the strong sharp bands at 1386 and 1384 cm-1 for [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O, respectively, revealed the presence of a free ionic nitrate group. The N‒N-chelating heterocycle rings generate bands characteristic of overlapping ν (C=N) and ν (C=C) stretching vibrations in the 1440–1600 cm−1 range. Furthermore, the out-of-plane vibration of the heterocyclic 1,10-phenanthroline ring in [Cu(HPf)(phen)(NO3)]NO3.2H2O appeared at 720 cm-1 while that to 2,2ʹ- bipyridine in [Cu(HPf)(bipy)(NO3)]NO3.2H2O was displayed at 779 cm-1 [19, 48], confirming the formation of mixed ligand complexes with distorted square-based pyramidal structures.

UV‒Vis spectroscopy

The bands appeared at 283,340 and 415 nm in the spectrum of pefloxacin were assigned to π- π *, n- π * and charge transfer transitions, respectively [27]. Upon complex formation, these bands were variably shifted with increasing intensities. The spectrum of [Cu(Pf)2(H2O)2].3H2O showed one broad asymmetric absorption band at 723 nm ascribed to the [2]Eg → 2T2g transition, suggesting an octahedral configuration [49]. Furthermore, the bands at 649 and 654 nm for [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O, respectively, are of penta-coordinated copper complexes having distorted square pyramidal geometry and are assigned to 2B12E1 transitions [50].

Mass spectroscopy

The mass spectra of [Cu(Pf)2(H2O)2]0.3H2O, [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O complexes (Additional file 1: Figures S1-S4) exhibited a peak with m/z 818, 713 and 737, respectively, consistent with their molecular weight, and their proposed fragmentation patterns are given in Schemes Additional file 1: S5- S8.

EPR spectroscopy

The spectrum of [Cu(Pf)2(H2O)2].3H2O at room temperature showed axial parameters g||(2.31) ˃g┴ (2.07) ˃ge (2.0023) representing dx2-y2 ground state copper(II) complexes and gav of 2.13 [51]. The value of the G- parameter 4.52 indicated no copper-copper interaction in the solid-state and intermediate ligand field. The hyperfine line splitting factor A|| of 170 G obtained from the spectrum is consistent with the distortion from planarity. The empirical factor ƒ has a value of 136 cm-1 representing a minor distortion in the equatorial plane. The covalency parameter of 0.85 also indicates significant in-plane covalent σ bonding [52].

The spectrum of [Cu(HPf)(bipy)(NO3)]NO3.2H2O showed an axial shape with g||>g┴, gav> 2.0023, and G = 4.5 with no existence of hyperfine lines in the perpendicular or parallel regions. The EPR spectrum for [Cu(HPf)(phen)(NO3)]NO3.2H2O has a rhombic nature. The spectrum showed three g values g3(2.57)>g2(2.14)> g1(1.97). The average g value of 2.23 and R value of 0.40, confirmed the dx2-y2 ground state [51, 52].

Fluorescence spectroscopy

The fluorescence emission spectra of pefloxacin (2.00 × 10–7 mol L−1) in the absence and presence of various concentrations of Cu2+ ions (1.00 × 10–8-5.00 × 10–3 mol L−1) are given in Fig. 1. As shown from the displayed spectra, with an excitation wavelength of 330 nm, the maximum emission wavelength of pefloxacin was 435 nm (Fig. 1a). The fluorescence intensity of pefloxacin decreased with increasing Cu2+ ion concentration (Fig. 1b-i), but no change in the maximum emission wavelength of HPf was observed. This observation could be attributed to the high affinity of Cu2+ ions to the carbonyl and carboxylic groups present in the pefloxacin molecule as a ligand [53] and that the ion can strongly quench the inner fluorescence of the pefloxacin ligand and that the interaction between the bioligand and metal ion indeed existed without inducing any conformational change in pefloxacin. Static quenching implies either the existence of a sphere of effective quenching or the formation of a ground state nonfluorescent complex. The observed static quenching mechanism of fluorescence was confirmed by applying Stern–Volmer technique [54] and calculating the quenching constant (Ksv) utilizing Eq. (1) at 25 °C and 35 °C. If Ksv decreases with increasing temperature, it is concluded that the quenching process is static rather than dynamic [55].

$${\text{F}}_{0} /{\text{F}} = { 1 } + {\text{ Ksv}}[{\text{Cu2}} + ]$$
Fig. 1
figure 1

The effect of Cu2+ ions concentration (1.00 × 10–7–5.00 × 10–3 mol L−1) on the fluorescence intensity of pefloxacin (2.00 × 10–7 mol L−1) at 25 °C (λex at 330, λem at 435 nm) a [Hpf] = 2.00 × 10–7 mol L−1, b upon addition of [Cu2+] = 1.00 × 10−7 mol L−1, c upon addition of [Cu2+] = 4.00 × 10–7 mol L−1, d upon addition of [Cu2+] = 1.00 × 10− 4 mol L−1, e upon addition of [Cu2+] = 2.00 × 10–4 mol L−1, f upon addition of [Cu2+] = 3.00 × 10–4 mol L−1, g upon addition of [Cu2+] = 1.00 × 10–3 mol L−1, h upon addition of [Cu2+] = 2.00 × 10–3 mol L−1, i upon addition of [Cu2+] = 5.00 × 10–3 molL.−1

Herein, F0 and F are the fluorescence intensities of the bioligand in the absence and presence of the Cu+2 quencher, respectively. The value of Ksv was calculated from the slope of the linear plot of F0/F vs [Cu2+] (Additional file 1: Figure S9).

From the experimental data in Additional file 1: Figure S9, it is clear that increasing temperature led to the decreased in Ksv value (Ksv = 0.151 × 104 Lmol−1 at 25 °C and 0.146 × 104 Lmol−1 at 35 °C). Inconclusion, quenching is typically initiated by static processes. Copper ions are known as strong quenchers because of their electronic structure (d9). Quenching by this type of substance most likely involves the donation of an electron from the fluorophore to the quencher.

Cu2+ usually presents low energy levels, which give rise to energy and electron transfer processes and can quench the fluorescent excited state of the molecule [55].

Detection of amino acids

To assess the copper-pefloxacin complex as a fluorescent probe for detecting various amino acids, several concentrations of amino acids, namely, alanine, aspartic acid, and proline, in 0.01 mol L−1 phosphate buffer solution (pH 7) were added to the nonfluorescent copper-pefloxacin complex solution. Figure 2 represents the changes in fluorescence intensity after the addition of different concentrations of aspartic acid (asp) in 0.01 mol L−1 phosphate buffer solution (pH 7), while the changes in the intensity of fluorescence spectra after the addition of different concentrations of proline and alanine are provided in the supplementary information (Additional file 1: Figures S10 and S11). When the amino acid was added to a solution of copper-pefloxacin complex, the pefloxacin in the copper-pefloxacin complex was replaced with the added amino acid forming a copper-amino acid complex. Consequently, quenching by copper(II) ions was inhibited, and the emission from pefloxacin was amplified drastically [56]. The suggested mechanism for amino acid determination was explained in equations.

$${\text{Cu}}^{{2^{ + } }} + {\text{ HL }} \to \, \left[ {{\text{Cu}}{-}{\text{L}}} \right] + {\text{ H}}$$
$$\left[ {{\text{Cu}}{-}{\text{L}}} \right] \, + {\text{ amino acid }} \to \, \left[ {{\text{Cu}}{-}{\text{amino acid}}} \right] + {\text{L}}$$
Fig. 2
figure 2

Changes of fluorescence intensity after addition of different concentrations of aspartic acid (asp) in 0.01 mol L−1 phosphate buffer solution (pH 7). [HPf] = 2.00 × 10–7 mol L−1, b upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1, c upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 2.00 × 10–3 mol L−1, d upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 4.00 × 10–3 mol L−1, e upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 6.00 × 10–3 mol L−1, f upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 1.00 × 10–2 mol L−1, g upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 3.00 × 10–2 mol L−1, h upon the addition of [Cu2+] = 5.00 × 10–3 mol L−1 and [asp] = 4.50 × 10–2 mol L−1 The acidic conditions were avoided during detection, and phosphate buffer solution at pH = 7 was used to allow the stability of the complex. Thus, amino acids act as competitors, as they reduce the quenching effect of Cu2+ ions from reacting with pefloxacin due to the development of a Cu–amino acid complex

The relative fluorescence intensity change for copper-pefloxacin complexes at 435 nm after the addition of 4.50 × 10–2 mol L−1 of different amino acids to 0.01 mol L−1 phosphate buffer solution containing [Cu2+] = 5.00 × 10−3 mol L−1and [Hpf] = 2.00 × 10–7 mol L−1for a pefloxacin solution as a probe is displayed in Additional file 1: Figure S12. Based on the obtained results, it is obvious that the rise in the intensity of fluorescence upon adding aspartic acid is notable from other amino acids. This may be due to the overall stability sequence of the copper complexes with amino acids, which follows the order aspartic acid < proline < alanine. Thus, aspartic acid can be simply determined fluorometrically upon using copper-pefloxacin solution probe. A good linear relationship between the concentration of aspartic acid, proline, and alanine and the fluorescence intensity was observed from the calibration curves of amino acids in pefloxacin solution at λmax 435 nm in 0.01 mol L−1 phosphate buffer solution (pH 7) at 298 K (Additional file 1: Figure S13). The linear range of the calibration curves for the pefloxacin solution was 2.00 × 10–3–4.5 × 10–2 mol L−1, 1.00 × 10–2– 4.5 × 10–2 mol L−1, and 2.00 × 10–2 –1.3 × 10–1 mol L−1 for aspartic acid, proline, and alanine, respectively. In conclusion, pefloxacin has a high fluorescence intensity, while copper- pefloxacin complex is weaker than copper-amino acid complexes. Thus, pefloxacin can be used as a probe for amino acids detection by copper ions.

Thermal analysis

Thermogravimetric analysis (TGA), derivative thermogravimetric analysis (DTG), and differential thermal analysis (DTA) investigated the thermal analysis of pefloxacin and its copper(II) complexes in a stream of nitrogen. Additionally, the % weight losses during the degradation stages were determined and predicted in terms of the molecular formula and are given in Table 1. The thermogravimetric analysis curve of pefloxacin mesylate dihydrate showed a strong degradation stage in the temperature range of 46-999 °C with a mass loss of 37.907% (calc. 37.834%) due to the loss of 2H2O, C2H4O13 and CO2. The residual solid corresponding to a mass of 62.093% (calc. 62.149%), which is equivalent to the C16H20FN3O residue. This step is accompanied by three exothermic DTA peaks at 60 °C, 143 °C and 234 °C.

Table 1 Thermal analysis of pefloxacin and its complexes

The three copper complexes displayed nearly similar types of thermal decomposition [57, 58]. The degradation continued, leaving copper metal in the binary complex and copper oxide in both ternary complexes as the end product. The observed results were in accordance to the proposed structures of the complexes.

Determination of thermodynamic parameters for Pefloxacin and its Cu(II) complexes

The thermodynamic parameters of the degradation process of pefloxacin and its copper(II) complexes, including the activation energy (Ea), enthalpy change (ΔH), and entropy change (ΔS), were estimated by performing the Horowitz-Metzger Eq. 59 and are listed in Additional file 1: Table S14. The order of the chemical reaction (n) was calculated by the peak symmetry method [60]. The values of the collision factor (Z) [61] were calculated from the relation:

$$Z = \frac{{E_{a} }}{{(RT_{m} )}}\phi \,exp\,\left( {\frac{{E_{a} }}{{(RT_{m}^{2} )}}} \right) = \,\frac{{KT_{m} }}{h}exp\,\left( {\frac{\Delta S}{R}} \right)$$

where (ΔS), (R), (ϕ) (K) and (h) represent the entropies of activation, molar gas constant, rate of heating (K S-1), Boltzmann constant, and Planck's constant, respectively [61]. The change in enthalpy (ΔH) for any phase transformation taking place at any peak temperature (Tm) can be given by the following equation (ΔS=ΔH/T) [62]. Based on the least square calculations, the LnΔT versus 1000/T plots for all complexes gave straight lines from which the activation energies were calculated according to the method of Piloyan et al. [63]. The slope is of the Arrhenius type and equals –Ea/R. With the foregoing discussion in mind, the TGA/DTG and TGA/DTA measurements revealed that copper complexes of pefloxacin undergo decomposition to form copper oxide as the final product except for [Cu(Pf)2(H2O)2].3H2O complex that undergoes decomposition to form elemental copper as a final product. The data resulting from the DTA curves revealed that the maximum and minimum values of the collision number (Z) are 2579 and 76, respectively, suggesting different mechanisms with variable speeds. Additionally, the values of the decomposed substance fraction (αm) at the maximum development of the reaction in each step are of similar magnitude and lie within the range 0.637–0.423. In addition, the (∆S) values for pefloxacin and its complexes are in the range of -0.184 to -0.218 kJK-1mol-1. The negative sign indicates that the transition states are more ordered and in a less random molecular configuration than the reacting complexes [64,65,66].

Finally, the (n) values suggest that the reaction is incomplete and/or proceeds in a complicated mechanism [67] the negative values of (∆H) indicate exothermic decomposition processes.

DFT calculations

Optimization and geometrical structure

The optimized geometrical structures of pefloxacin and its complexes are displayed with numbering systems in Figure 3 The geometrical parameters (bond lengths and bond angles) are computed and tabulated in Table 2. In the [Cu(Pf)2(H2O)2].3H2O complex, the copper atom is coordinated with two water molecules and two bidentate pefloxacin molecules, forming a six-coordinate octahedral complex. The bond lengths around the Cu atom refer to the group axial position, where Cu1-O1 andCu1-O8 are 2.369 Å and 2.425 Å, respectively. The two H-bonding bonds C2---H1 and C5--- H41 with bond lengths of 2.627 Å and 2.712 Å, respectively, can enhance the stability of complex formation.

Fig. 3
figure 3

The optimized structures of (a) pefloxacin (b) [Cu(Pf)2(H2O)2].3H2O (c) [Cu(HPf)(bipy)(NO3)]NO3.2H2O (d) [Cu(HPf)(phen)(NO3)]NO3.2H2O, using DFT/B3LYP/LanL2DZ/6-311G(d,p) method

Table 2 Theoretical geometric parameters (bond lengths and bond angles) for copper (II) based pefloxacin complexes

The bond angles around the copper center involved the presence of the complex in the distorted octahedral structure. However, in [Cu(HPf)(bipy)(NO3)]NO3.2H2O, the copper atom is coordinated to O4 and O5 from pefloxacin with bond lengths of 1.908 Å and 1.927 Å, respectively, and to O2 of the nitrate group, in addition to N1 and N6 from the bipyridine ligand at 2.002 Å and 2.010 Å, respectively, to complete the five-coordinate copper(II) complex. The bond length values confirmed the axial position of O2 due to bond elongation. The bond angles of a copper basal plane (between Cu and O4, O5, N1, and N6 atoms) indicate distorted square pyramidal geometry. For the [Cu(HPf)(phen)(NO3)]NO3.2H2O complex, the copper atom is coordinated to O3 of the nitrate molecule, O4, and O5 of the pefloxacin molecule in addition to N1 and N2 of the phenanthroline molecule. The bond length of Cu1-O3 is 2.249 Å, indicating the axial position of the nitrate group, and the bond angles around the copper confirmed its distorted square pyramidal geometry.

Quantum and reactivity parameters

To determine the electronic behavior of pefloxacin and its copper(II) complexes, the chemical reactivity parameters, including Frontier molecular orbital (FMO) energies, electronegativity (χ), ionization potential (I), electron affinity (A), dipole moment (D), chemical potential (µ), chemical hardness (η) and global softness (S), are calculated and given in Table 3.

Table 3 Quantum and reactivity parameters of pefloxacin and its copper(II) complexes

FMOs mainly represent two types of orbitals, the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), that verify the reactivity and stability of compounds.

The high value of EHOMO represents the ease of the compound donating an electron to the unoccupied orbital of the molecule that acts as a receptor, while the low ELUMO value explains the small resistance of the molecule to accepting electrons. The energy gap (ΔE) is the difference between FMO (HOMO-LUMO) energies.

Both the I and the A values are related to EHOMO and ELUMO, which are helpful parameters in predicting the ability of the molecule to donate or accept electrons. As the studied complexes have lower I and higher A (3.945 eV) than the corresponding pefloxacin ligand, the complexes may act as electron donor systems.

The binary [Cu(Pf)2(H2O)2].3H2O complex showed a higher ΔE (4.110 eV), indicating higher stability and forming a complex with lower reactivity. In contrast, the [Cu(HPf)(bipy)(NO3)]NO3.2H2O complex has a lower energy gap (3.544 eV), demonstrating higher reactivity and lower stability. The global reactivity descriptors (chemical hardness and global softness) are based on the I and A parameters. A higher η (2.055 eV) and lower S (0.243 eV) for the [Cu(Pf)2(H2O)2] complex.3H2O indicates its lower reactivity [68]. The electrophilicity index ω measures the energy change when the system becomes saturated with electrons and is given by ω = μ2/2η. The global softness is calculated from S = 1/2η.

Figure 4 shows that the electronic orbital densities dispersed on the HOMO and LUMO of the examined complexes involve the copper center coordinated with the ligand.

Fig. 4
figure 4

Electronic distribution of FMOs for the optimized compounds where a pefloxacin b [Cu(Pf)2(H2O)2].3H2O c [Cu(HPf)(bipy)(NO3)]NO3.2H2O d [Cu(HPf)(phen)(NO3)]NO3.2H2O

This dispersion ensures the possible transition of electrons from the HOMO to LUMO levels. The following equations describe the calculated parameters: [69]

$${\text{Ionization potential }}\left( {\text{I}} \right) = \, - {\text{EHOMO}}$$
$${\text{Electron affinity }}\left( {\text{A}} \right) = - {\text{ELUMO}}$$
$${\text{Chemical hardness }}\left( \eta \right) \, = \left( {{\text{I}} - {\text{A}}} \right)/{2}$$
$${\text{Chemical potential }}\left( \mu \right) \, = \, - \left( {{\text{I }} + {\text{A}}} \right)/{2}$$
$${\text{Electronegativity }}\left( \chi \right) \, = \, - ({\text{EHOMO}} + {\text{ELUMO}})/{2}$$
$${\text{Electrophilicity index}}\left( \omega \right) = \mu {2}/{2}\eta$$
$${\text{Global softness }}\left( {\text{S}} \right) \, = {1}/{2}\eta$$

Natural bond orbital (NBO) analysis and molecular electrostatic potential (MEP) profiles

The natural charge on each atom (except Hydrogens) of pefloxacin and its complexes after optimization are compiled in Additional file 1: Table S15, where the charge value predicts the active sites in the molecule. The charges on O2 and O3 of pefloxacin are − 0.364 and—0.341, respectively. This relatively high electronic charge indicates that the coordinative ligand atoms with the metal form a stable complex. The reactivity of the studied complexes can be described by the analysis of MEP to perceive the intra- and intermolecular interactions in the investigated compounds. Different color codes appear in this MEP analysis evaluating the active sites in the compound.

The colored map of MEP for pefloxacin and its complexes are described in Fig. 5, where the electron density ranged from red to blue, corresponding to the highest and lowest electron density on the surface. In pefloxacin, the negative potential is attributed to O1, O2, and O3 atoms, which represent the active sites for coordination with the metal ion to form the complex, confirming the same results as in the NBO population. MEP of [Cu(Pf)2(H2O)2]0.3H2O indicated that the charge density delocalized on oxygen atoms of water and oxygen atoms of pefloxacin surround the copper center, which supports the electron-rich coordination region and stabilizes the electronic system.

Fig. 5
figure 5

MEP surface of the optimized structures (a) pefloxacin (b) [Cu(Pf)2(H2O)2].3H2O (c) [Cu(HPf)(bipy)(NO3)]NO3.2H2O (d) [Cu(HPf)(phen)(NO3)]NO3.2H2O

In the case of complexes Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O, the electron density appeared to be poor around the coordination sphere, which may be attributed to the zwitter ion present in the complex that makes the surface potential on the surface mainly positive.

Topological properties of Pefloxacin and [Cu(Pf)2(H2O)2]0.3H2O (NCI-RDG analysis)

Noncovalent bond interactions (NCIs) between diverse parts of the compound were detected using reduced density gradient (RDG) analysis. To apply RDG analysis in our study, the pefloxacin ligand and [Cu(Pf)2(H2O)2].3H2O complex were selected to perform this topological analysis. The different noncovalent interactions presented different color codes [70, 71] where the blue color represents a strong HB attraction that occurs between the oxygen of quinolone C=O and the carboxylic OH. In addition to the coordinated ligand sites that occur in the complex, there is a noncovalent HB interaction around the metal ion involving the bonding of water hydrogens with the coordinated pefloxacin oxygen atoms that describes the extensive stability of the complex. The green color represents electrostatic (vdW) interactions, while the red color indicates strong repulsion between the entries of the molecules distributed on different regions of pefloxacin and its copper complex [Cu(Pf)2(H2O)2].3H2O.

The sign (λ2)ρ is a parameter describing the multiplication of the electron density with the sign of the second Hessian eigenvalue; it measures the strength of HB interaction in compounds and distinguishes this type from other interactions. The most negative sign (λ2)ρ value expresses strong HB (blue color), and the most positive sign (λ2)ρ value is evidence of strong steric interaction. As shown in Figure 6 plot (b) appeared as three spikes. In the case of pefloxacin, the low negative density gradient spike (sign(λ2)ρ < -0.03) corresponded to intramolecular pefloxacin H-bonding, while the second negative spike (0< sign(λ2)ρ > -0.03) corresponded to the van der Waals interactions that mostly occurred in the nonpolar hydrocarbons. When the spike moved to a positive RDG area (sign(λ2)ρ < 0.01), a strong repulsion interaction mostly occurred between the aromatic rings of the compound. In the case of [Cu(Pf)2(H2O)2].3H2O, the H-bonding density gradient spike is shifted to a lower negative value (sign(λ2)ρ< -0.04) due to the formation of several HBs during metal-ligand complexation. Additionally, the second negative spike of the van der Waals interaction appears to be dispersed with a lower density gradient value.

Fig. 6
figure 6

NCI isosurfaces a and RDG scatter mapping diagrams b of the optimized pefloxacin and its binary complex

Antimicrobial activities

Pefloxacin and its three complexes were executed in vitro against six pathogenic microorganisms, two gram-positive bacteria: B. subtilis and S. pneumoniae, two gram-negative bacteria E. coli and P. aeruginosa, two pathogenic fungi: C. albicans and A. fumigatus whereas Gentamicin and Ampicillin worked as standard bactericides and amphotericin B served as a fungicide.

The susceptibility of the pathogenic microorganisms to the compounds was refereed by measuring the diameter of the inhibition zone, and the data are summarized in Table 4. The bacterial screening data revealed that pefloxacin and its Cu(II) complexes exhibited activity against Escherichia coli and displayed better activity than Gentamicin. However, no activity was demonstrated against P.aeruginosa. The antibacterial activities were well-ordered as follows:

$$[{\text{Cu}}({\text{Pf}})_{2} ({\text{H}}_{2} {\text{O}})_{2} ] \cdot {3\text{H}}_{2} {\text{O}} > {\text{HPf}} > [{\text{Cu}}({\text{HPf}})({\text{bipy}})({\text{NO}}_{3})]{\text{NO}}_{3} \cdot {2\text{H}}_{2} {\text{O}} > [{\text{Cu}}({\text{HPf}})({\text{phen}})({\text{NO}}_{3})]{\text{NO}}_{3} \cdot {2\text{H}}_{2} {\text{O}}$$
Table 4 Antimicrobial screening results of pefloxacin and its complexes evaluated by the mean inhibition zone in mm

The binary pefloxacin-Cu complex exhibited improved antibacterial activity compared to pefloxacin and the corresponding ternary complexes. Enhanced activity was observed against S. pneumonia compared to ampicillin. It was observed that pefloxacin and its ternary complexes did not show any noticeable antifungal activity, while the binary complex [Cu(Pf)2(H2O)2]0.3H2O showed moderate activities against A. fumigates. Based on the screened results, it is obvious that the [Cu(Pf)2(H2O)2]0.3H2O complex showed higher activity than free pefloxacin against some of the screened pathogenic microorganisms. This may be elucidated by chelation theory and overtone's concept [72,73,74,75].

The complex enhanced the lipophilic character of the central copper atom, that favors its permeation via the lipid bilayer of the microorganism's membrane and blocked the metal-binding sites on the enzymes of the microorganism, thus destroying them more aggressively. Reportedly, metal complexes have exclusive modes of action: ligand exchange or release, catalytic generation of toxic species, redox activation and/or depletion of essential substrates. Such mechanisms are hard or otherwise impossible to replicate with organic ligands [76].

Nevertheless, the effectiveness of complexes in several organisms depends on the impermeability of the cells of the microbes or on the changes in ribosomes in microbial cells [77]. The binary octahedral complex [Cu(Pf)2(H2O)2]0.3H2O demonstrated great effectiveness relative to the other prepared five-coordinate distorted square-based pyramidal complexes, [Cu(HPf)(bipy)(NO3)]NO3.2H2O and [Cu(HPf)(phen)(NO3)]NO3.2H2O. This may be due to its capability of forming strong M-L bonds which enhance its lipophilic character and its penetration into the lipid membrane, causing restriction in the growth of the microorganism. This outcome may be ascribed to its high coordination number and/or its octahedral geometry.

The change in the antimicrobial activity between the two prepared five-coordinate distorted square-based pyramidal copper complexes may be due to the change of heterocyclic rings involved in the coordination sphere [78]. However, [Cu(HPf)(bipy)(NO3)]NO3.2H2O demonstrated improved activity against the studied microorganisms compared with [Cu(HPf)(phen)(NO3)]NO3.2H2O. Surprisingly, these observations are not consistent with those in reported studies [19, 24, 79], which stated that mixed ligand complexes with 1,10-phenanthroline as a secondary ligand manifested improved antibacterial activity compared with other nitrogen donor heterocyclic ligands, owing to the nuclease activity of this ligand when complexed to copper.

Protein binding screen evaluation

To investigate the bioactive mode, molecular docking was applied to DFT-optimized pefloxacin and its copper complexes, and the docking pocket was downloaded as a PDB file with two protein codes according to the microbial organism (E. coli and S. pneumoniae). Pefloxacin is well known as a powerful bioactive agent in the field of pharmaceutical drugs based on its higher functional activity owing to the best score achievement [80,81,82,83]. Herein, computational docking will investigate the protein binding modes of pefloxacin copper complexes. Figure 7 represents the 3D docking analysis of the studied complexes with 5I2D and 6O15 protein targets involving solvent accessible surfaces. Additional file 1: Tables S16 and S17 include the evaluated energies and discuss the comparable validity of the studied complexes to bind with different amino acids of E. coli protein ID: 5I2D and S. pneumonia (ID: 6O15) 6O15. According to the experimental data illustrating the antimicrobial activity, it was found that [Cu(Pf)2(H2O)2]0.3H2O had a better antimicrobial activity, and a molecular docking screen confirmed this result since [Cu(Pf)2(H2O)2]0.3H2O has a higher fitness (TBE = − 107.7 kcal/mol) than the other two complexes. The higher fitness comes from binding with 21 amino acids in the protein pocket, where the total fitness (TBE) of pefloxacin with protein is − 87.3 kcal/mol. Figure 8 shows the number of amino acids interacting with the optimized complexes in different interaction types, such hydrogen bonding (conventional and carbon), alkyl and π-stacking interactions.

Fig. 7
figure 7

3D-schematic representation of the docked complexes, a [Cu(Pf)2(H2O)2].3H2O, b [Cu(HPf)(bipy)(NO3)]NO3.2H2O, c [Cu(HPf)(phen)(NO3)]NO3.2H2O, compared with HPf, in two protein types with solvated surface accessibility

Fig. 8
figure 8

3D and 2D interactions and H-bond distances between E. coli amino acids (ID: 5I2D) and the studied complexes

To investigate the docking behavior on other bacterial target types, the protein crystal structure of S. pneumoniae with the 6O15 code was chosen. Additional file 1: Table S18 shows the fitness values of the three studied complexes compared with pefloxacin, where [Cu(HPf)(bipy)(NO3)]NO3.2H2O has a fitness score (TBE = − 116.150 kcal/mol) during the docking process. This result does not agree with the experimental data where [Cu(Pf)2(H2O)2]0.3H2O experimentally has the best result, which may be attributed to the mode of docking where the active functional groups attract different numbers of amino acids at the same time as the energy affected by these interactions. There are other intermolecular interactions, such as H-bonding and vdW interactions. Figure 9 demonstrates the labeled interacting amino acids of the 6O15 crystal structure with the studied copper complexes in addition to the presence of the H-bond distance between the interacting parts. Recently, a spectral range of fluoroquinolones (including pefloxacin derivative) were studied against docking performance. G Venkateswara rao et al [84] investigated that this class behave as a good inhibiting systems and powerful antibacterial ability towards several bacterial target protein-microbes.

Fig. 9
figure 9

3D and 2D interactions and H-bond distances between S. pneumoniae amino acids (ID: 6O15) and the studied complexes


In summary, three solid copper(II) complexes of pefloxacin (HPf) were synthesized in the absence and presence of two nitrogen donor heterocyclic ligands. The structure of the complexes was investigated by analytical, spectroscopic (FTIR, UV–Vis, EPR, and mass spectrometry), and thermal (TGA, DTG and DTA) techniques. Spectral data suggested the formation of one octahedral binary copper complex and distorted square pyramidal geometry for two ternary copper complexes. Additionally, the pefloxacin –Cu [2]+ complex was used as a competitive turn-on fluorescence probe for the detection of amino acid.

A computational study was performed in a gas state, and quantum and reactivity parameters were calculated. Electrophilic and nucleophilic behavior were described using MEP, where the center of copper-pefloxacin in the octahedral binary complex is electron-rich, while it is electron poor in the other two complexes. Pefloxacin and its Cu(II) complexes were in vitro screened against B.subtilis, S. pneumoniae, E. coli, P. aeruginosa, C. albicans, and A. fumigatus. The octahedral binary copper complex demonstrated great effectiveness relative to the ternary complexes; thus, it can be considered a powerful antimicrobial broad-spectrum drug that may be able to perform some microbial resistance. Docking simulation was performed with the crystal structure of E. coli and S. pneumoniae receptors using 5I2D and 6O15 codes, and the interactions occurring in the protein–ligand complexes were predicted. Noncovalent interaction analysis confirmed the presence of different types of interactions in which hydrogen bond formation was the most important interaction.

Availability of data and materials

All data generated or analyzed during this study are included in this manuscript and supplementary materials.


  1. Khan SA, Rizwan K, Shahid S, Noamaan MA, Rasheed T, Amjad H, Synthesis DFT. computational exploration of chemical reactivity, molecular docking studies of novel formazan metal complexes and their biological applications. Appl Organomet Chem. 2020.

    Article  Google Scholar 

  2. Sarangi AK, Mahapatra BB, Mohapatra RK, Sethy SK, Das D, Lucia Pintilie Md, Kudrat-E-Zahan MA, Meher H. Synthesis and characterization of some binuclear metal complexes with a pentadentate azodye ligand: an experimental and theoretical study. Appl Organomet Chem. 2020.

    Article  Google Scholar 

  3. Redgrave LS, Sutton SB, Webber MA, Piddock LJV. Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014.

    Article  PubMed  Google Scholar 

  4. Naqvi SAR, Drlica K. Fluoroquinolones as imaging agents for bacterial infection. Dalton Trans. 2017.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ferreira M, Gameiro P. Fluoroquinolone-transition metal complexes: a strategy to overcome bacterial resistance. Microorganisms. 2021;9:1506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Verma N, Jha KK, Sharma R, Singh NK, Singh AK. Fluoroquinolones-a new definition of antibiotics. Internat J. 2014;2:373–8.

    Google Scholar 

  7. Saraiva R, Lopes S, Ferreira M, Novais F, Pereira E, Feio MJ, Gameiro P. Solution and biological behaviour of enrofloxacin metalloantibiotics: a route to counteract bacterial resistance? J Inorg Biochem. 2010;104:843–50.

    Article  CAS  PubMed  Google Scholar 

  8. Feio MJ, Sousa I, Ferreira M, Cunha-Silva L, Saraiva RG, Queirós C, Alexandre JG, Claro V, Mendes A, Ortiz R, et al. Fluoroquinolone–metal complexes: A route to counteract bacterial resistance? J Inorg Biochem. 2014;138:129–43.

    Article  CAS  PubMed  Google Scholar 

  9. Batista DG, Silva PB, Stivanin L, Lachter DR, Silva RS, Felcman J, Louro SR, Teixeira LR, Maria de Nazaré CS. Co(II), Mn(II) and Cu(II) complexes of fluoroquinolones: synthesis, spectroscopical studies and biological evaluation against Trypanosoma cruzi. Polyhedron. 2011.

    Article  Google Scholar 

  10. Djurdjevic P, Jakovljevic I, Joksovic L, Ivanovic N, Jelikic-Stankov M. The effect of some fluoroquinolone family members on biospeciation of copper(II), Nickel(II) and Zinc(II) ions in human plasma. Molecules. 2014;19:12194–223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Nunes WD, Nascimento AL, Moura A, Gaglieri C, Vallim GB, Nascimento LC, Mendes R, Ionashiro M, Caires F. Thermal, spectroscopic and antimicrobial activity characterization of some norfloxacin complexes. J Therm Anal Calorim. 2018;132:1077–88.

    Article  CAS  Google Scholar 

  12. Aljohani FS, Omran OA, Ahmed EA, Al-Farraj ES, Elkady EF, Alharbi A, El-Metwaly NM, Barnawi IO, Abu-Dief AM. Design, structural inspection of new bis(1H-benzo[d]imidazol-2-yl)methanone complexes: biomedical applications and theoretical implementations via DFT and docking approaches. Inorganic Chem Commun. 2023.

    Article  Google Scholar 

  13. Hany MA, Mai MK, Mohamed RS, Ahmed MA. Fabrication, DFT calculation, and molecular docking of two Fe(III) Imine Chelates as Anti-COVID-19 and pharmaceutical drug candidate. Int J Mol Sci. 2022;23(7):3994.

    Article  CAS  Google Scholar 

  14. Enas TA, Mohamed RS, Ahmed MA. Design, synthesis, structural inspection of Pd2+, VO2+, Mn2+, and Zn2+ chelates incorporating ferrocenyl thiophenol ligand: DNA interaction and pharmaceutical studies. App Organo Chem. 2021;35(4):e6169.

    Article  CAS  Google Scholar 

  15. Abu-Dief AM, Abdel-Rahman LH, Abdelhamid AA, Marzouk AA, Shehata MR, Bakheet MA, Almaghrabi OA, Nafady A. Synthesis and characterization of new Cr(III), Fe(III) and Cu(II) complexes incorporating multi-substituted aryl imidazole ligand: structural, DFT, DNA binding, and biological implications. Spectrochim Acta A Mol Biomol Spectrosc. 2020.

    Article  PubMed  Google Scholar 

  16. Khalil TE, El-Dissouky A, Al-Wahaib D, Abrar NM, El-Sayed DS. Synthesis, characterization, antimicrobial activity, 3D-QSAR, DFT and molecular docking of some ciprofloxacin derivatives and their copper(II) complexes. Appl Organomet Chem. 2020;34:e5998.

    Article  CAS  Google Scholar 

  17. Dorotíková S, Kožíšková J, Malček M, Jomová K, Herich P, Plevová K, Briestenská K, Chalupková A, Mistríková J, Milata V, Dvoranová D. Copper(II) complexes with new fluoroquinolones: synthesis, structure, spectroscopic and theoretical study, DNA damage, cytotoxicity and antiviral activity. J Inorg Biochem. 2015;150:160–73.

    Article  CAS  PubMed  Google Scholar 

  18. Živec P, Perdih F, Turel I, Giester G, Psomas G. Different types of copper complexes with the quinolone antimicrobial drugs ofloxacin and norfloxacin: structure, DNA- and albumin-binding. J Inorg Biochem. 2012;117:35–47.

    Article  CAS  PubMed  Google Scholar 

  19. Elhusseiny AF, El-Dissouky A, Mautner F, Tawfik EM, El-Sayed DS. An insight into non-covalent interactions in binary, ternary and quaternary copper (II) complexes: Synthesis, X-ray structure, DFT calculations, antimicrobial activity and molecular docking studies. Inorganica Chim Acta. 2022;532:120748–63.

    Article  CAS  Google Scholar 

  20. Lawal M, Obaleye JA, Jadeja RN, Bamigboye MO, Gupta VK, Roy H, Shaikh IU. Copper(II) mixed-ligand complexes with fluoroquinolones and N-donor co-ligand: structures and biological application. Polyhedron. 2020.

    Article  Google Scholar 

  21. Martins DA, Gouvea LR, Muniz GS, Louro SRW, Batista DD, Soeiro MD, Teixeira LR. Norfloxacin and N-Donor Mixed-Ligand Copper(II) complexes: synthesis albumin interaction, and anti-trypanosoma cruzi activity. Bioinorg Chem Appli. 2016;2016(2):1–11.

    Article  CAS  Google Scholar 

  22. Sakr SH, Elshafie HS, Camele I, Sadeek SA. Synthesis, spectroscopic, and biological studies of mixed ligand complexes of gemifloxacin and glycine with Zn(II), Sn(II), and Ce(III). Molecules. 2018;23:1182–99.

    Article  CAS  PubMed  Google Scholar 

  23. Sadeek SA, Abd El-Hamid SM, El-Shwiniy WH. Synthesis, spectroscopic characterization, thermal stability and biological studies of mixed ligand complexes of gemifloxacin drug and 2,2’-bipyridine with some transition metals. Res Chem Intermed. 2016;42:3183–208.

    Article  CAS  Google Scholar 

  24. Ruta LL, Farcasanu IC, Bacalum M, Raileanu M, Rostas AM, Daniliuc C, Chifiriuc MC, Marutescu L, Popa M, Badea M, Iorgulescu EE, Olar R. Biological activity of triazolopyrimidine copper(II) complexes modulated by an auxiliary N-N-chelating heterocycle ligands. Molecules. 2021;26:6772–825.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rostas AM, Badea M, Ruta LL, Farcasanu IC, Maxim C, Chifiriuc MC, Popa M, Luca M, Korosin NC, Korosec RC, Bacalum M, Raileanu M, Olar R, et al. Copper(II) complexes with mixed heterocycle ligands as promising antibacterial and antitumor species. Molecules. 2020;25:3777–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chikira M, Ng CH, Palaniandavar M. Interaction of DNA with simple and mixed ligand copper(II) complexes of 1,10-phenanthrolines as studied by DNA-Fiber EPR spectroscopy. Int J Mol Sci. 2015;16:22754–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Soayed AA, Refaat HM, El-Din DAN. Characterization and biological activity of Pefloxacin–imidazole mixed ligands complexes. Inorganica Chim Acta. 2014;421:59–66.

    Article  CAS  Google Scholar 

  28. Muslu H, Golcu A, Tumer M, Ozsoz M. Electrochemical investigation and DNA-binding studies of pefloxacin–metal(II/III) complexes. J Coord Chem. 2011;64(19):3393–407.

    Article  Google Scholar 

  29. Onyenze U, Otuokere IE, Igwe JC. Co(II) and Fe(II) mixed ligand complexes of pefloxacin and ascorbic acid: synthesis, characterization and antibacterial studies. Res J Appl Sci Eng Technol. 2016;8:215–20.

    Article  Google Scholar 

  30. Bassett J., Denney R., Jeffery G.H., J. Mendham, editors, Vogel's textbook of quantitative inorganic analysis including elementary instrumental analysis, Longman, 1987.

  31. Frisch M. J. et al, Gaussian 09, Revision A.02, Gaussian, Inc., Wallingford CT, 2016.

  32. Parr RG, Yang W. Density-functional theory of atoms and molecules. New York: Oxford University Press; 1989.

    Google Scholar 

  33. Fayed TA, Gaber M, Abu El-Reash GM, El-Gamil MM. Structural, DFT/B3LYP and molecular docking studies of binuclear thiosemicarbazide Copper (II) complexes and their biological investigations. Appl Organomet Chem. 2020;34:e5800.

    Article  CAS  Google Scholar 

  34. Becke AD. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys. 1993;98:5648–52.

    Article  CAS  Google Scholar 

  35. López JB, González JC, Holguín NF, Mitnik DG. Quantum chemical study of a new class of sensitisers: influence of the substitution of aromatic rings on the properties of copper complexes. Mol Phys. 2014;112(7):987–94.

    Article  CAS  Google Scholar 

  36. Zhurko G., Zhurko D., ChemCraft 1.8 2005.

  37. Dennington R., Keith T.A., Millam J.M., GaussView, Version 6.1, Semichem Inc., Shawnee Mission, KS, 2016.

  38. Hsu KC, Chen YF, Lin SR, Yang JM. iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform. 2011.

    Article  Google Scholar 

  39. Abu-Dief AM, Abdel-Rahman LH, Abd-El Sayed MA, Zikry MM, Nafady A. Green Synthesis of AgNPs() ultilizing delonix regia extract as anticancer and antimicrobial agents. Chem Select. 2020;5(42):13263–8.

    Article  CAS  Google Scholar 

  40. Saddik MS, Elsayed MMA, Abdelkader MSA, El-Mokhtar MA, Abdel-Aleem JA, Abu-Dief AM, Al-Hakkani MF, Farghaly HS, Abou-Taleb HA. Novel green biosynthesis of 5-fluorouracil chromium nanoparticles using harpullia pendula extract for treatment of colorectal cancer. Pharmaceutics. 2021;13(2):226.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Abu-Dief AM, Alrashedee FMM, Emran KM, Al-Abdulkarim HA. Development of some magnetic metal–organic framework nano composites for pharmaceutical applications. Inorg Chem Commun. 2022.

    Article  Google Scholar 

  42. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12.

    Article  CAS  PubMed  Google Scholar 

  43. Feng Y, Zhang Y, Ebright RH. Structural basis of transcription activation. Science. 2016;352:1330–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Horne CR, Kind L, Davies JS, Dobson RCJ. On the structure and function of Escherichia coli YjhC: an oxidoreductase involved in bacterial sialic acid metabolism. Proteins. 2020;88:654–68.

    Article  CAS  PubMed  Google Scholar 

  45. Finegold S. M., Martin W. J., Louis S., Diagnostic Microbiology, 6th ed., London, 1982.

  46. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493–6.

    Article  CAS  PubMed  Google Scholar 

  47. Geary WJ. Coord The use of conductivity measurements in organic solvents for the characterisation of coordination compounds. Chem Rev. 1971;7:81–122.

    CAS  Google Scholar 

  48. Galani A, Efthimiadou EK, Mitrikas G, Sanakis Y, Psycharis V, Raptopoulou C, Kordas G, Karaliota A. Synthesis, crystal structure and characterization of three novel copper complexes of Levofloxacin. Study of their DNA binding properties and biological activities. Inorganica Chim Acta. 2014;423:207–18.

    Article  CAS  Google Scholar 

  49. Yamada S, Takeuchi A. The conformation and interconversion of schiff base complexes of nickel(II) and copper(II). Coord Chem Rev. 1982;43:187–204.

    Article  CAS  Google Scholar 

  50. Herrera AM, Staples RJ, Krjatov SV, Nazarenko AY, Akimova EVR. Nickel(II) and copper(II) complexes with pyridine-containing macrocycles bearing an aminopropyl pendant arm: synthesis, characterization, and modifications of the pendant amino group. Dalton Trans. 2003;5:864–856.

    Google Scholar 

  51. Hathaway B, Billing DE. The electronic properties and stereochemistry of mono-nuclear complexes of the copper(II) ion. Coord Chem Rev. 1970;5(2):143–207.

    Article  CAS  Google Scholar 

  52. Kivelson D, Neiman R. ESR studies on the bonding in copper complexes. J Chem Phys. 1961;35:149–55.

    Article  CAS  Google Scholar 

  53. Abdelrehim EM, El-Sayed DS. A new synthesis of poly heterocyclic compounds containing [1,2,4] triazolo and [1,2,3,4] tetrazolo moieties and their DFT study as expected anti-cancer reagents. Curr Org Synth. 2020;17:211–23.

    Article  CAS  PubMed  Google Scholar 

  54. Chandra AK, Uchimara T. Hardness profile: a critical study. J Phys Chem A. 2001;105(14):3578–82.

    Article  CAS  Google Scholar 

  55. Rodrigues T, Dos Santos DJ, Moreira R, Lopes F, Guedes RC. A quantum mechanical study of novel potential inhibitors of cytochrome bc1 as antimalarial compounds. Int J Quantum Chem. 2011;111:1196–207.

    Article  CAS  Google Scholar 

  56. Venkataramanan NS, Suvitha A. Theoretical investigation of the binding of nucleobases to cucurbiturils by dispersion corrected DFT approaches. J Phys Chem B. 2017;121:4733–44.

    Article  CAS  PubMed  Google Scholar 

  57. Xie L, Xiao N, Li L, Xie X, Li Y. Theoretical insight into the interaction between chloramphenicol and functional monomer (Methacrylic Acid) in molecularly imprinted polymers. Int J Mol Sci. 2020;21(11):4139.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Mahmoud WH, Omar MM, Sayed FN. Synthesis, spectral characterization, thermal, anticancer and antimicrobial studies of bidentate azo dye metal complexes. J Therm Anal. 2016;124:1071–89.

    Article  CAS  Google Scholar 

  59. Horowitz HH, Metzger G. A new analysis of thermogravimetric traces. Anal Chem. 1963;35:1464–8.

    Article  CAS  Google Scholar 

  60. Kissinger HE. Reaction kinetics in differential thermal analysis. Anal chem. 1957;29:1702–6.

    Article  CAS  Google Scholar 

  61. Dhar ML, Singh O. Kinetics and thermal decomposition of Fe(III) and UO2(II) complexes with embelin (2,5-dihydroxy-3-undecyl-P-benzoquinone). J Therm Anal. 1991;37:259–65.

    Article  CAS  Google Scholar 

  62. Traore K. Analyse thermique differentielle et cinetique de reaction III surface des pics d’analyse thermique differentielle et applications. J Therm Anal. 1972;4(2):135–45.

    Article  CAS  Google Scholar 

  63. Piloyan GO, Ryabchikov ID, Novikova OS. Determination of activation energies of chemical reactions by differential thermal analysis. Nature. 1966;212:1229.

    Article  CAS  Google Scholar 

  64. Dhar ML, Singh O. Kinetics and thermal decomposition of Fe(III) and UO2(II) complexes with embelin (2,5-dihydroxy-3-undecyl-P-benzoquinone). J Therm Anal Calorim. 1991;37:259–65.

    Article  CAS  Google Scholar 

  65. Abdel-Rahman LH, Abu-Dief AM, Ismael M, Mohamed MAA, Hashem NA. Synthesis, structure elucidation, biological screening, molecular modeling and DNA binding of some Cu(II) chelates incorporating imines derived from amino acids. J Mol Str. 2016.

    Article  Google Scholar 

  66. Al-Radadi NS, Abu-Dief AM. Silver nanoparticles (AgNPs) as a metal nano-therapy: possible mechanisms of antiviral action against COVID-19. Inorg Nano-Metal Chem. 2022.

    Article  Google Scholar 

  67. Mallikarjun KG, Naidu RS. Thermal decomposition kinetics of Cu(II) chelates of substituted chalcones. Thermochim Acta. 1992;206:273–8.

    Article  CAS  Google Scholar 

  68. Sultana N, Arayne MS, Rizvi SBS, Haroon U, Mesaik MA. Med Chem Res. 2013;22:1371–7.

    Article  CAS  Google Scholar 

  69. Tigineh GT, Abiye M, Melese A, Abebe A. Synthesis, Structural investigations, and in vitro biological activity of Co(II) and Fe(III) mixed ligand complexes of 1,10-phenanthroline and 2,2’-bipyridine. Chem Biol Drug Des. 2021.

    Article  PubMed  Google Scholar 

  70. Sultana N, Naz A, Arayne MS, Mesaik MA. Synthesis, characterization, antibacterial, antifungal and immunomodulating activities of gatifloxacin-metal complexes. J Mol Struct. 2010;969:17–24.

    Article  CAS  Google Scholar 

  71. Fernandes P, Sousa I, Cunha-Silva L, Ferreira M, de Castro B, Pereira EF, Feio MJ, Gameiro P. synthesis, characterization and antibacterial studies of a copper(II) lomefloxacin ternary complex. J Inorg Biochem. 2014;131:21–9.

    Article  CAS  PubMed  Google Scholar 

  72. Ferreira M, Gameiro P. Fluoroquinolone-Transition metal complexes: a strategy to overcome bacterial resistance. Microorganisms. 2021;9:1506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Soayed AA, Refaat HM, El-Din DAN. Metal complexes of moxifloxacin–imidazole mixed ligands: characterization and biological studies. Inorganica Chim Acta. 2013;406:230–40.

    Article  CAS  Google Scholar 

  74. Sha L, Tang X, Liu D, Xu Y, Ding Y, Ding F. Detection and quantitation of lomefloxacin and pefloxacin residues in the organ tissues and eggs of laying hens. J Food Prot. 2018;81:810–4.

    Article  CAS  PubMed  Google Scholar 

  75. Farokhcheh A, Alizadeh N. Amino acid detection using fluoroquinolone–Cu2+ complex as a switch-on fluorescent probe by competitive complexation without derivatization. J Lumin. 2014;145:708–12.

    Article  CAS  Google Scholar 

  76. Amjadi M, Farzampour L. Fluorescence quenching of fluoroquinolones by gold nanoparticles with different sizes and its analytical application. J Lumin. 2014;145:263–8.

    Article  CAS  Google Scholar 

  77. Wang C, Wu QH, Li CR, Wang Z, Ma JJ, Zang XH, Qin NX. Interaction of tetrandrine with human serum albumin: a fluorescence quenching study. Anal Sci. 2007;23:429–33.

    Article  PubMed  Google Scholar 

  78. Doğan A, Köseoğlu F, Kılıç E. The stability constants of copper(II) complexes with some α-Amino acids in dioxan-water mixtures. Anal Biochem. 2001;295(2):237–9.

    Article  CAS  PubMed  Google Scholar 

  79. Abu-Dief AM, Alotaibi NH, Al-Farraj ES, Qasem HA, Alzahrani S, Mahfouz MK, Abdou A. Fabrication, structural elucidation, theoretical, TD-DFT, vibrational calculation and molecular docking studies of some novel adenine imine chelates for biomedical applications. J Mol Liquids. 2022.

    Article  Google Scholar 

  80. Qasem HA, Aouad MR, Al-Abdulkarim HA, Al-Farraj ES, Attar RMS, El-Metwaly NM, Abu-Dief AM. Tailoring of some novel bis-hydrazone metal chelates, spectral based characterization and DFT calculations for pharmaceutical applications and in-silico treatments for verification. J Mol Struct. 2022.

    Article  Google Scholar 

  81. Abu-Dief AM, El-Metwaly NM, Alzahrani SO, Alkhatib F, Abualnaja MM, El-Dabea T, Ali MA. Synthesis and characterization of Fe(III), Pd(II) and Cu(II)-thiazole complexes; DFT, pharmacophore modeling, in-vitro assay and DNA binding studies. J Mol Liquids. 2021.

    Article  Google Scholar 

  82. Sayed DSE, Abdelrehim ESM. Spectroscopic details on the molecular structure of pyrimidine-2-thiones heterocyclic compounds: computational and antiviral activity against the main protease enzyme of SARS-CoV-2. BMC Chem. 2022.

    Article  PubMed  PubMed Central  Google Scholar 

  83. El Sayed DS, Abdelrehim El-M. Computational details of molecular structure, spectroscopic properties, topological studies and SARS-Cov-2 enzyme molecular docking simulation of substituted triazolo pyrimidine thione heterocycles. Spectr Acta Part A: Mol Biomol Spect. 2021.

    Article  Google Scholar 

  84. Gollapalli VR, Bollikolla HB, Allaka TR, Vaddi PRR, Basireddy S, Ganivada M, Pindii SR. New fluoroquinolone–1,2,4–triazoles as potent antibacterial agents: design, synthesis, docking studies and in silico ADME profile. Chem Biodiversity. 2023.

    Article  Google Scholar 

Download references


Not applicable


Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations



DSEl-S: Software, Validation, Visualization, Formal analysis, and Writing- Original draft preparation. EMT: Synthesis and Investigation AmelFElH: Supervision, Conceptualization, Visualization, Investigation, Writing- Original draft preparation, Writing- Reviewing and Editing. AEl-D: Supervision, Methodology, Visualization, Conceptualization, Reviewing and Editing. All authors read approved the final manuscript.

Corresponding author

Correspondence to Doaa S. El-Sayed.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

No potential conflict of interest was reported by the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Figure S1:

Mass spectrum of pefloxacin mesylate dehydrate. Figure S2: Mass spectrum of [Cu22].3H2O. Figure S3: Mass spectrum of [Cu]NO3.2H2O. Figure S4: Mass spectrum of [Cu]NO3.2H2O. Figure S5: Fragmentation pattern of pefloxacin mesylate dehydrate. Figure S6: Fragmentation pattern of [Cu22].3H2O. Figure S7: Fragmentation pattern of [Cu]NO3.2H2O. Figure S8: Fragmentation pattern of [Cu]NO3.2H2O. Figure S9: Stern- Volmer plot for the addition of different Cu2+ ion concentration to HPf solution at 25 oC and 35 oC. Figure S10: Changes of fluorescence intensity after addition of different concentrations of prolinein 0.01 mol L-1 phosphate buffer solution: [HPf] = 2.00x10-7 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1 and [pro] = 1.00x10-2 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1 and [pro] = 2.00x10-2 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1 and [pro] = 3.00x10-2 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1 and [pro] = 4.00x10-2 mol L-1, upon the addition of [Cu2+] = 5.00x10-3 mol L-1 and [pro] = 4.50x10-2 mol L-1. Figure S11: Changes of fluorescence intensity after addition of different concentrations of alanine in 0.01 mol L-1 phosphate buffer solution: [HPf] = 2.00x10-7 mol L-1, upon adding [Cu2+] = 5.00x10-3 mol L-1, upon adding [Cu2+] = 5.00x10-3 mol L-1 and [alanine] = 6.00x10-2 mol L-1, upon adding [Cu2+] = 5.00x10-3 mol L-1 and [alanine] = 9.00x10-2 mol L-1, upon adding [Cu2+] = 5.00x10-3 mol L-1 and [alanine] = 1.30x10-1 mol L-1. Figure S12: Relative flourescence intensity changes for Cu–pefloxacin complex at 435 nm after the addition of 4.50 x 10-2 mol L-1 of different amino acids to the 0.01 mol L-1 phosphate buffer solution. Figure S13: Calibration curves of aspartic acid, proline and alanine in pefloxacin solution at λmax 435 nm in 0.01 mol L-1 phosphate buffer solutionat 298 K. Table S14: Kinetic parameters of pefloxacin and its complexes. Table S15. NBO charge on atoms of pefloxacin and its copper complexes using DFT with CAM-B3LYP/ LanL2DZ/6-311G. Table S16: Binding energy distribution of different 5I2D amino acids with pefloxacin and its complexes. Table S17: Binding energy distribution of different 6O15 amino acids with pefloxacin and its complexes. Table S18: Fitness parameters of docked compounds with E. coli and S. pneumoniae.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Sayed, D.S., Tawfik, E.M., Elhusseiny, A.F. et al. A perception into binary and ternary copper (II) complexes: synthesis, characterization, DFT modeling, antimicrobial activity, protein binding screen, and amino acid interaction. BMC Chemistry 17, 55 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: